000 01325 a2200385 4500
005 20250512222739.0
264 0 _c19841206
008 198412s 0 0 eng d
022 _a0300-8835
024 7 _a10.3109/00016348409157006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTobiassen, T
245 0 0 _aDanazol treatment of severely symptomatic fibrocystic breast disease and long-term follow-up--the Hjørring project.
_h[electronic resource]
260 _bActa obstetricia et gynecologica Scandinavica. Supplement
_c1984
300 _a159-76 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBreast Diseases
_xdrug therapy
650 0 4 _aDanazol
_xadverse effects
650 0 4 _aFemale
650 0 4 _aFibrocystic Breast Disease
_xdiagnosis
650 0 4 _aFollow-Up Studies
650 0 4 _aHumans
650 0 4 _aMammography
650 0 4 _aMiddle Aged
650 0 4 _aPain
_xdrug therapy
650 0 4 _aPalpation
650 0 4 _aPregnadienes
_xtherapeutic use
650 0 4 _aRecurrence
700 1 _aRasmussen, T
700 1 _aDöberl, A
700 1 _aRannevik, G
773 0 _tActa obstetricia et gynecologica Scandinavica. Supplement
_gvol. 123
_gp. 159-76
856 4 0 _uhttps://doi.org/10.3109/00016348409157006
_zAvailable from publisher's website
999 _c6593839
_d6593839